CASP3 and lung adenocarcinoma: Third, our immunoblotting experiments showed that AM-101 treatment in vitro does not enhance cleavage of pro-caspase 3 in lung adenocarcinoma cells (Figure S4D) even at concentrations higher than its IC50.